Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients
- Ventilated Patients
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrolment target
- 24
- Started
- 17 February 2026
- Main results due
- February 2028
- Study sites
- 1
- Registry updated
- 29 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Tracheostomy and mechanical ventilation 3. Dyspnea ≥3 4. Consent to participate 5. Affiliation to health insurance Exclusion Criteria: 1. Agitation, delirium 2. Continuous use of sedatives 3. Patients under law protection 4. Inmates 5. Patients without health insurance 6. Breastfeeding and pregnancy
What this study is about
In the sponsor’s own words, from the registry.
The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.
Study sites(1)
Hôpital Pitié Salpêtrière
Paris, France
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07308171. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me